2 active not recruiting, 1 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 2, Completed 1 |
Follow Estrogen Receptor Negative: new trials by email Literature Review of Estrogen Receptor Negative trials Research Report on Estrogen Receptor Negative
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy Capecitabine, Carboplatin, Cisplatin - Estrogen Receptor Negative, HER2/Neu Negative | Phase 3 | Active not recruiting | ECOG-ACRIN Cancer Research Group | 415 | 2015-10-20 | 2026-11-02 |
| Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride - Breast Adenocarcinoma, Estrogen Receptor Negative | Phase 3 | Active not recruiting | NRG Oncology | 782 | 2015-07-26 | 2026-05-06 |
| Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Bevacizumab, Ixabepilone, Laboratory Biomarker Analysis - Estrogen Receptor Negative, Estrogen Receptor Positive | Phase 3 | Completed | National Cancer Institute (NCI) | 799 | 2008-10-13 | 2026-06-23 |
Breast Neoplasms (3) · Triple Negative Breast Neoplasms (2)
Breast Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3)
Carboplatin (2) · Paclitaxel (2) · Taxes (2) · 130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Bevacizumab (1) · Capecitabine (1) · Cisplatin (1) · Cyclophosphamide (1) · Disulfides (1) · Doxorubicin (1) · Epothilones (1) · Immunoglobulin G (1) · ixabepilone (1)
ECOG-ACRIN Cancer Research Group (1) · NRG Oncology (1) · National Cancer Institute (NCI) (1)
United States (3) · Canada (1) · Puerto Rico (1) · South Africa (1)
Hope S Rugo (1) · Ingrid Mayer (1) · Vicente Valero (1)
PMID 26056183, PMID 28620884, PMID 34092112, PMID 34616010, PMID 38236702, PMID 39169033
U10CA031946 (1), U10CA180820 (1), U10CA180821 (1), U10CA180868 (1), U24CA196172 (1)